⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALLR News
Allarity Therapeutics, Inc. Common Stock
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
globenewswire.com
ALLR
Form 8-K
sec.gov
VBIO
ALLR
Form 8-K
sec.gov
ALLR
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
globenewswire.com
ALLR
Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration
globenewswire.com
ALLR
Form 8-K
sec.gov
ALLR
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
globenewswire.com
ALLR
Form 8-K
sec.gov
ALLR
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
globenewswire.com
ALLR
Form 8-K
sec.gov
ALLR